Publicaciones en colaboración con investigadores/as de University of Helsinki (167)

2024

  1. JAK inhibitor treatment for inborn errors of JAK/STAT signaling: An ESID/EBMT-IEWP retrospective study

    Journal of Allergy and Clinical Immunology, Vol. 153, Núm. 1, pp. 275-286.e18

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Baseline risk factors of in-hospital mortality after surgery for acute type A aortic dissection: an ERTAAD study

    Frontiers in Cardiovascular Medicine, Vol. 10

  3. Current Outcome after Surgery for Type A Aortic Dissection

    Annals of Surgery, Vol. 278, Núm. 4, pp. E885-E892

  4. Direct Aortic Versus Supra-Aortic Arterial Cannulation During Surgery for Acute Type A Aortic Dissection

    World Journal of Surgery, Vol. 47, Núm. 11, pp. 2899-2908

  5. Intelligent digital tools for screening of brain connectivity and dementia risk estimation in people affected by mild cognitive impairment: the AI-Mind clinical study protocol

    Frontiers in Neurorobotics, Vol. 17

  6. Interinstitutional analysis of the outcome after surgery for type A aortic dissection

    European Journal of Trauma and Emergency Surgery, Vol. 49, Núm. 4, pp. 1791-1801

  7. Monogenic early-onset lymphoproliferation and autoimmunity: Natural history of STAT3 gain-of-function syndrome

    Journal of Allergy and Clinical Immunology, Vol. 151, Núm. 4, pp. 1081-1095

  8. Nutrition education in medical schools (NEMS) project: Promoting clinical nutrition in medical schools – Perspectives from different actors

    Clinical Nutrition

  9. Preoperative arterial lactate and outcome after surgery for type A aortic dissection: The ERTAAD multicenter study

    Heliyon, Vol. 9, Núm. 10

  10. Prognostic Models for Global Functional Outcome and Post-Concussion Symptoms Following Mild Traumatic Brain Injury: A Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI) Study

    Journal of Neurotrauma, Vol. 40, Núm. 15-16, pp. 1651-1670

  11. Prospective evaluation of the efficacy, safety, and optimal biomarker enrichment strategy for nangibotide, a TREM-1 inhibitor, in patients with septic shock (ASTONISH): a double-blind, randomised, controlled, phase 2b trial

    The Lancet Respiratory Medicine, Vol. 11, Núm. 10, pp. 894-904

  12. Schizophrenia risk conferred by rare protein-truncating variants is conserved across diverse human populations

    Nature genetics, Vol. 55, Núm. 3, pp. 369-376

  13. Sex differences in the effectiveness of first-line tumour necrosis factor inhibitors in axial spondyloarthritis: Results from the EuroSpA Research Collaboration Network

    RMD Open, Vol. 9, Núm. 4

  14. WAO consensus on DEfinition of Food Allergy SEverity (DEFASE)

    World Allergy Organization Journal, Vol. 16, Núm. 3